Genprex, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 18, 2020, details the results of Genprex, Inc.'s 2020 Annual Meeting of Stockholders. The company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol GNPX. As of the record date (April 20, 2020), 32,854,841 shares of common stock were outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 21,121,645 shares were present at the meeting, representing approximately 64.29% of outstanding shares. Two proposals were voted upon:
- Proposal 1: Election of Directors. Stockholders elected two Class III Directors to serve until the 2023 Annual Meeting.
- Jose A. Moreno Toscano: 6,165,114 votes For; 63,079 votes Withheld; 14,893,452 Broker Non-Votes.
- J. Rodney Varner: 5,854,575 votes For; 373,618 votes Withheld; 14,893,452 Broker Non-Votes.
- Proposal 2: Ratification of Independent Auditor. Stockholders ratified the selection of Daszkal Bolton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- Votes For: 20,756,998
- Votes Against: 180,046
- Abstention: 184,601
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding (32,854,841) and the percentage of shares present at the meeting (64.29%).
- Confirm the significant number of Broker Non-Votes (14,893,452) recorded for the election of directors, which indicates shares held by brokers that were not voted due to lack of instructions.
- Confirm the ratification of Daszkal Bolton LLP as the independent auditor for the 2020 fiscal year.